These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8410185)

  • 21. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
    Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-Methyl-4-phenylpyridinium-induced down-regulation of dopamine transporter function correlates with a reduction in dopamine transporter cell surface expression.
    Chagkutip J; Vaughan RA; Govitrapong P; Ebadi M
    Biochem Biophys Res Commun; 2003 Nov; 311(1):49-54. PubMed ID: 14575693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    Staal RG; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cloning and functional expression of the mouse dopamine transporter.
    Brüss M; Wieland A; Bönisch H
    J Neural Transm (Vienna); 1999; 106(7-8):657-62. PubMed ID: 10907725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.
    Speciale SG; Liang CL; Sonsalla PK; Edwards RH; German DC
    Neuroscience; 1998 Jun; 84(4):1177-85. PubMed ID: 9578404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters.
    Scholze P; Sitte HH; Singer EA
    Neurosci Lett; 2001 Aug; 309(3):173-6. PubMed ID: 11514069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HEK-293 cells expressing the human dopamine transporter are susceptible to low concentrations of 1-methyl-4-phenylpyridine (MPP+) via impairment of energy metabolism.
    Storch A; Ludolph AC; Schwarz J
    Neurochem Int; 1999 Nov; 35(5):393-403. PubMed ID: 10517700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury.
    Pan T; Fei J; Zhou X; Jankovic J; Le W
    Life Sci; 2003 Jan; 72(9):1073-83. PubMed ID: 12495785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Staal RG; Yang JM; Hait WN; Sonsalla PK
    Brain Res; 2001 Aug; 910(1-2):116-25. PubMed ID: 11489261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter.
    Pifl C; Khorchide M; Kattinger A; Reither H; Hardy J; Hornykiewicz O
    Neurosci Lett; 2004 Jan; 354(1):34-7. PubMed ID: 14698476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the major transport pathway for the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.
    Dunigan CD; Shamoo AE
    Neuroscience; 1996 Nov; 75(1):37-41. PubMed ID: 8923521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding.
    Kitayama S; Shimada S; Xu H; Markham L; Donovan DM; Uhl GR
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7782-5. PubMed ID: 1502198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of dopamine and MPP+ transport by catecholamine transporters.
    Dohi T; Kitayama S; Morioka N; Kumagai K; Mitsuhata C; Morita K; Kozai K; Lin Z; Uhl GR
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):43-7. PubMed ID: 15164608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairment of the neuronal dopamine transporter activity in MPP(+)-treated rat was not prevented by treatments with nitric oxide synthase or poly(ADP-ribose) polymerase inhibitors.
    Barc S; Page G; Barrier L; Piriou A; Fauconneau B
    Neurosci Lett; 2001 Nov; 314(1-2):82-6. PubMed ID: 11698152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K; Trevor AJ; Castagnoli N
    Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP.
    Arora PK; Riachi NJ; Fiedler GC; Singh MP; Abdallah F; Harik SI; Sayre LM
    Life Sci; 1990; 46(5):379-90. PubMed ID: 2304377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
    Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
    Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.